Predictive validity of SOFA-2: analytical and contextual considerations - Report - MDSpire

Predictive validity of SOFA-2: analytical and contextual considerations

  • By

  • Li Xinyue

  • Shi Hui

  • Ji Shan

  • July 1, 2026

  • 0 min

Share

---

Clinical Report: Evaluating the Predictive Accuracy of SOFA-2

Overview

The study provides an independent validation of the SOFA-2 score against 30-day mortality in nearly 30,000 ICU admissions, revealing a small discriminative advantage over SOFA-1. However, significant analytical concerns regarding reclassification, predictive validity decay, case-mix dependency, and component validation are raised.

Background

The Sequential Organ Failure Assessment (SOFA) score is a critical tool in assessing organ dysfunction in ICU settings. The introduction of SOFA-2 aims to modernize this assessment, reflecting contemporary clinical practices.

Data Highlights

The study analyzed nearly 30,000 ICU admissions, with SOFA-2 demonstrating an AUROC of 0.81 on day 1 compared to 0.80 for SOFA-1. The net reclassification improvement between SOFA-1 and SOFA-2 was only 0.09, with 75.5% of admissions being reclassified. The predictive validity of SOFA declined from 0.81 on day 1 to approximately 0.70 by day 7, and the brain subscore had the highest day 1 AUROC of 0.73.

Key Findings

  • SOFA-2 showed a small discriminative advantage over SOFA-1 on ICU day 1 (AUROC 0.81 vs 0.80).

  • 75.5% of admissions were reclassified between SOFA-1 and SOFA-2, but net reclassification improvement was only 0.09.

  • Day 1 AUROC for trauma patients was 0.81, while for sepsis patients it was only 0.72.

  • SOFA predictive validity declined from 0.81 on day 1 to approximately 0.70 by day 7.

  • The brain subscore had the highest day 1 AUROC (0.73) and strongest odds ratio per point (1.60).

  • SOFA-2-specific components were not manually validated, raising concerns about potential extraction errors.

Clinical Implications

Clinicians should be cautious in interpreting SOFA-2 scores, especially in high-severity cases.

Conclusion

The advantages of SOFA-2 appear to be confined to early ICU assessments, with significant limitations in specific patient groups and concerns regarding component validation.

Related Resources & Content

  1. Helleberg et al., Critical Care, 2026 -- Evaluating the Predictive Accuracy of SOFA-2

  2. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score | Emergency Medicine | JAMA | JAMA Network, 2025

  3. Critical Care (Springer) — Reevaluating the Ease of Implementing SOFA-2: A Practical Approach to Assessment

  4. Frontiers in Anesthesiology — Comparison of SOFA score alone versus SOFA score with interleukin-6 for outcome prediction in ICU patients with sepsis: a prospective observational study

  5. Frontiers in Psychiatry — Module-specific diagnostic accuracy of ADOS-2 in real-world clinical referral populations: an updated systematic review and HSROC meta-analysis

  6. Intensive Care Medicine — SAPS 3—Transitioning from Patient Assessment to Intensive Care Unit Evaluation: Part 2 - Creation of a Prognostic Model for In-Hospital Mortality at ICU Admission

  7. Reevaluating the Ease of Implementing SOFA-2: A Practical Approach to Assessment

  8. Comparison of SOFA score alone versus SOFA score with interleukin-6 for outcome prediction in ICU patients with sepsis

  9. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score | Emergency Medicine | JAMA | JAMA Network

  10. Predictive validity of daily sequential organ failure assessment (SOFA)-2 score for 30-day mortality | Critical Care | Springer Nature Link

  11. Surviving Sepsis Campaign Adult Guidelines | SCCM

---

Original Source(s)

Related Content